Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis

NACompletedINTERVENTIONAL
Enrollment

1,095

Participants

Timeline

Start Date

June 20, 2022

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2023

Conditions
Human African TrypanosomiasisSleeping SicknessTrypanosoma Brucei Gambiense; InfectionWest African Sleeping Sickness
Interventions
DIAGNOSTIC_TEST

Serological field test for HAT

Whole blood is tested by lateral flow or agglutination (CATT) for the presence of trypanosome specific antibody. Participants testing positive for at least one of these tests will undergo microscopic examination to detect trypanosomes (lymph, mAECT on blood) and DBS will be prepared for immunological and molecular laboratory testing.

DIAGNOSTIC_TEST

malaria rapid test

RDT detecting HRP2 plasmodium antigen.

DIAGNOSTIC_TEST

Immunologic laboratory tests

Laboratory tests detecting trypanosoma brucei gambiense specific (VSG) antibodies in DBS. These tests will only be carried out on participants that are positive in at least on of the rapid serological tests

DIAGNOSTIC_TEST

Molecular laboratory tests

Laboratory tests detecting Trypanozoon specific nucleic acids. These tests will only be carried out on participants that are positive in at least on of the rapid serological tests

Trial Locations (2)

Unknown

Université Jean Lorougnon Guédé de Daloa, Bonon

Programme Nationale de Lutte contre la Trypanosomiase Humaine Africaine, Ministère de Santé, Division Prévention et Lutte contre la Maladie, Dubréka

All Listed Sponsors
collaborator

Foundation for Innovative New Diagnostics

UNKNOWN

collaborator

Programme National de lutte contre la THA, Guinée

UNKNOWN

collaborator

Université Jean Lorougnon Guédé, Daloa

UNKNOWN

collaborator

Institut Pasteur, Guinée

UNKNOWN

collaborator

Institut Pierre Richet, Guinée

UNKNOWN

lead

Institut de Recherche pour le Developpement

OTHER_GOV